Volpara and image analysis developer ScreenPoint Medical have signed an MOU which will see the two companies seek to bring ScreenPoint’s artificial intelligence–based Transpara detection and decision support software to...
In this interview, Dr Ralph Highnam, CEO provides insight into the FY2018 results and outlines the Company’s goals for FY2019.
When Volpara Health Technologies first commenced operations, we were a traditional medical device company—we built software products, sold them and then went back to the purchaser when we had something...
Cancer is the ultimate egalitarian, anyone is susceptible. This makes it the most fascinating of subjects.
In this interview, Dr Ralph Highnam, CEO provides his perspective on the year that was, including updates on progress and sets out targets for the year ahead.
Volpara CEO Ralph Highnam discusses the 2017 Full Year Financial Results and gives a sales update.
You may think a degree in math or physics is reserved for more bookish types that aim for career paths in labs, academia, or sci-fi-esque pursuits.